Immersion Corporation (NASDAQ:IMMR) reported Total revenues for the fourth quarter of 2015 were $16.6 million, an increase of 22% compared to $13.6 million for the fourth quarter of 2014. Royalty and license revenues of $15.8 million for the fourth quarter of 2015 were up 18% from the same period last year. Net income for the fourth quarter of 2015 was $1.1 million, or $0.04 per diluted share. This compares to net income of $1.0 million, also $0.04 per diluted share, for the fourth quarter of 2014.
Immersion Corporation (NASDAQ:IMMR) belongs to Technology sector. Its net profit margin is 4.50% and weekly performance is 13.58%. On last trading day company shares ended up at $9.03.
On February 10, 2016, Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) provided notice to The Schepens Eye Research Institute, Inc. (“Schepens”) of the Company’s termination of the License Agreement dated July 13, 2010, as amended, between the Company and Schepens (the “License Agreement”), to be effective 60 days following receipt of such notice by Schepens.
Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) shares moved up 1.42% in last trading session and ended the day at $0.28. EBIO return on assets is -61.10%. Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) quarterly performance is -90.47%.
Evans Bancorp, Inc. (NYSE MKT:EVBN), a community financial services company serving Western New York since 1920, announced that its Board of Directors declared a cash dividend of $0.38 per share on its outstanding common stock, a 6% increase from its previous dividend paid on October 6, 2015. The dividend is payable on April 5, 2016 to shareholders of record as of March 15, 2016. The Company has approximately 4.3 million shares outstanding.
On 26 February, Evans Bancorp Inc. (NYSEMKT:EVBN) shares remains unchanged and was closed at $24.41. EVBN EPS growth in last 5 year was 50.30%. Evans Bancorp Inc. (NYSEMKT:EVBN) year to date (YTD) performance is -5.09%.
Trinity Biotech plc (NASDAQ:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2015 on Thursday, March 3, 2016. The Company has scheduled a conference call for that same day, Thursday, March 3, 2016 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.
Trinity Biotech plc (NASDAQ:TRIB) ended the last trading day at $9.82. Company weekly volatility is calculated as 2.19% and price to cash ratio as 443.72. Trinity Biotech plc (NASDAQ:TRIB) showed a weekly performance of 1.24%.
China Zenix Auto International Limited (NYSE:ZX) shares fell -0.95% in last trading session and ended the day at $1.04. ZX Gross Margin is 13.80% and its return on assets is 1.00%. China Zenix Auto International Limited (NYSE:ZX) quarterly performance is 35.06%.